INS and Lipoatrophy: The present case report adds to the evidence, that a subclinical, subacute inflammatory reaction may be involved in the pathogenesis of insulin-induced lipoatrophy, since the destructive process may be suppressed and even reversed by administration of anti-inflammatory compounds (e.g. corticosteroids, disodium cromoglycate ointment).